Morgan Stanley, Kidder, and Capital Research Global Investors increased their holdings or boosted positions in Eli Lilly shares.
3 reports, 2 independent
Updated Sep 4
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley, Kidder, and Capital Research Global Investors increased their holdings or boosted positions in Eli Lilly shares.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Morgan Stanley increased its stake in Eli Lilly stock, and the company filed required reports with the SEC.Sub-event
Multiple firms boosted positions/holdings in Eli Lilly shares.1 source
Keep exploring
The entities involved
-
Eli Lilly and Company
American pharmaceutical company
-
Morgan Stanley
U.S. investment bank
Related events
- Nvidia, Eli Lilly, and Booking Holdings are high-growth stocks attracting investor attention, with Eli Lilly being specifically compared to Booking Holdings' stock split.
- Financial firms, including Royal Bank of Canada, Santander Group, Lazard, and Morgan Stanley, upgraded ratings and increased holdings based on company performance.
- Morgan Stanley increased its position in the iShares Morningstar Mid-Cap Growth ETF.